Profil
Linda Sjöström joined BankInvest Biomedical Venture team as Partner in early 2001.
She focuses on investments within drug discovery and drug development.
Mrs. Sjöström has been an active member of the venture capital community for more than 14 years, working with life science and biotechnology for Danish Venture Finance A/S and now BankInvest.
Before that she worked more than 17 years in the pharmaceutical industry.
Prior positions include Managing Director of the Danish subsidiary of Syntex Inc. (now bought by Roche) and other positions with Schering, Ciba-Geigy (now Novartis) and Rhône-Poulenc (now Aventis).
Mrs. Sjöström holds a master's degree in Chemical Engineering with an emphasis on Biochemistry.
Postes actifs de Linda Sjöström
| Sociétés | Poste | Début |
|---|---|---|
Meabco A/S
 Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Directeur/Membre du Conseil | - |
Anciens postes connus de Linda Sjöström
| Sociétés | Poste | Fin |
|---|---|---|
BioStratum, Inc.
 BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 05/07/2011 |
BI Technology A/S
 BI Technology A/S Investment ManagersFinance BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark. | Private Equity Investor | 01/02/2009 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | - |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | - |
ACE BioSciences ApS
 ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| Entreprise privées | 5 |
|---|---|
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
BI Technology A/S
BI Technology A/S Investment ManagersFinance BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark. | Finance |
Meabco A/S
Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Health Technology |
